The use of first-generation long-acting injectable antipsychotics in children and adolescents-A retrospective audit from India.
Sign Up to like & getrecommendations! Published in 2021 at "Asian journal of psychiatry"
DOI: 10.1016/j.ajp.2021.102663
Abstract: OBJECTIVES There is a dearth of knowledge regarding the usage of first-generation long-acting injectable (LAI) antipsychotics in children and adolescents, despite their off-label use, in low and middle-income countries (LAMIC). METHODS Case records of subjects… read more here.
Keywords: first generation; lai antipsychotics; antipsychotics children; generation ... See more keywords
Recognising side effects of antipsychotics in children with intellectual disabilities
Sign Up to like & getrecommendations! Published in 2023 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-251974
Abstract: Risperidone and aripiprazole are increasingly used for behavioural indications in children and adolescents with intellectual disabilities, including autism. Although there are some reports in literature, the side effect profile in this population remains poorly defined… read more here.
Keywords: intellectual disabilities; effects antipsychotics; antipsychotics children; recognising side ... See more keywords
Acceptability, equity, and feasibility of using antipsychotics in children and adolescents with autism spectrum disorder: a systematic review
Sign Up to like & getrecommendations! Published in 2020 at "BMC Psychiatry"
DOI: 10.1186/s12888-020-02956-8
Abstract: Background It is unclear whether the administration of antipsychotics to children and adolescents with autism spectrum disorders (ASD) is acceptable, equitable, and feasible. Methods We performed a systematic review to support a multidisciplinary panel in… read more here.
Keywords: equity; antipsychotics children; acceptability; evidence ... See more keywords